SCHEMBL7907352

SCHEMBL7907352

Cc1cc2c(cc1C(=O)N1CCc3ccccc3C1CN)[nH]c(=O)c1cnc(C3CCOCC3)n12

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDE9A O76083 11/20 0.41
PDE5A O76074 1/20 0.40
PDE1A P54750 3/20 0.35
PDE1B Q01064 3/20 0.35
PDE1C Q14123 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
SPR P35270 3/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
THRB P10828 1/20 0.34
HPGD P15428 1/20 0.34
HTT P42858 1/20 0.34
MMP14 P50281 1/20 0.34
KMT2A Q03164 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12044086 0.91 PDE9A (0.39) PDE9APDE5APDE1APDE1BPDE1C
SCHEMBL7908222 0.90 PDE9A (0.39) PDE9APDE5APDE1APDE1BPDE1C
SCHEMBL7905991 0.86 PDE9A (0.49) PDE9APDE5A
SCHEMBL7908218 0.86 PDE9A (0.40) PDE9APDE5APDE1ASPR
SCHEMBL7906346 0.85 PDE9A (0.39) PDE9APDE5ASPRMEN1KMT2A
SCHEMBL7896928 0.84 PDE9A (0.45) PDE9APDE5ASMN1; SMN2SPRKDM4E
SCHEMBL10186206 0.83 PDE9A (0.44) PDE9APDE5ASMN1; SMN2SPRKDM4E
SCHEMBL1721345 0.82 PDE9A (0.47) PDE9APDE5APDE1APDE1BPDE1C
SCHEMBL7908759 0.81 PDE9A (0.46) PDE9APDE5ASPRALDH1A1HPGD
SCHEMBL7900336 0.81 PDE9A (0.42) PDE9APDE5APDE1APDE1BPDE1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2404922-A1 QUINOXALINE COMPOUNDS Astellas Pharma Inc. (JP) 2012-01-11 EP disclosed
WO-2010101230-A1 QUINOXALINE COMPOUNDS アステラス製薬株式会社 (JP) 2010-09-10 WO disclosed